Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Morphine sulphate 20mg suppositories 1 suppository |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Morphine sulphate 20mg suppositories (Unichem Plc) 12 suppository |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Ebetrex 7.5mg/0.75ml solution for injection pre-filled syringes (Sandoz Ltd) 1 pre-filled disposable injection |
VMP non-availability indicator |
False |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Ebetrex 15mg/1.5ml solution for injection pre-filled syringes (Sandoz Ltd) 1 pre-filled disposable injection |
VMP non-availability indicator |
False |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Metoject 7.5mg/0.75ml solution for injection pre-filled syringes (medac UK) 1 pre-filled disposable injection |
VMP non-availability indicator |
False |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Morphine sulphate 20mg suppositories (Special Order) 1 suppository |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Morphine sulphate 20mg suppositories (Martindale Pharmaceuticals Ltd) 12 suppository |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Metoject 15mg/1.5ml solution for injection pre-filled syringes (medac UK) 1 pre-filled disposable injection |
VMP non-availability indicator |
False |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Ebetrex 10mg/1ml solution for injection pre-filled syringes (Sandoz Ltd) 1 pre-filled disposable injection |
VMP non-availability indicator |
False |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Metoject 10mg/1ml solution for injection pre-filled syringes (medac UK) 1 pre-filled disposable injection |
VMP non-availability indicator |
False |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Morphine sulphate 20mg suppositories (A A H Pharmaceuticals Ltd) 12 suppository |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Prednisolone 20mg/application foam enema (A A H Pharmaceuticals Ltd) |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Prednisolone 20mg/application foam enema (A A H Pharmaceuticals Ltd) 14 dose |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Product containing precisely cortisone acetate 25 milligram/1 each conventional release oral tablet |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Cortisone 25mg tablets (Unichem Plc) |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Cortisone 25mg tablets (A A H Pharmaceuticals Ltd) |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Cortisone 25mg tablets 1 tablet |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Cortisone 25mg tablets (Special Order) |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Cortisone 25mg tablets 56 tablet |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Cortisone 25mg tablets (sanofi-aventis) |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Cortisone 25mg tablets (Unichem Plc) 56 tablet 4 x 14 tablets |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Cortisone 25mg tablets (Special Order) 1 tablet |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Cortisone 25mg tablets (sanofi-aventis) 56 tablet |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Cortisone 25mg tablets (A A H Pharmaceuticals Ltd) 56 tablet 4 x 14 tablets |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Product containing precisely sulfasalazine 50 milligram/1 milliliter conventional release oral suspension |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Sulfasalazine 250mg/5ml oral suspension (Special Order) |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Salazopyrin 250mg/5ml suspension (Pfizer Ltd) |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Sulfasalazine 250mg/5ml oral suspension 500 ml |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Sulfasalazine 250mg/5ml oral suspension 1 ml |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Salazopyrin 250mg/5ml suspension (Pfizer Ltd) 500 ml |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Sulfasalazine 250mg/5ml oral suspension (Special Order) 1 ml |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Artelac Single Dose Unit 0.32% eye drops 0.5ml unit dose (Doncaster Pharmaceuticals Ltd) |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Dovonex 50micrograms/g ointment (LEO Pharma) 30 gram |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Artelac Single Dose Unit 0.32% eye drops 0.5ml unit dose (Doncaster Pharmaceuticals Ltd) 30 unit dose |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Product containing precisely dydrogesterone 10 milligram/1 each conventional release oral tablet |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Testosterone 5mg/24hours transdermal patch |
VMP non-availability indicator |
False |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Testosterone 5mg/24hours patches 30 patch |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Dydrogesterone 10mg tablets 1 tablet |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Dydrogesterone 10mg tablets 42 tablet |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Androderm 5mg/24hours transdermal patches (Imported (United States)) |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Dydrogesterone 10mg tablets 60 tablet |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Dydrogesterone 10mg tablets (Special Order) |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Duphaston 10mg tablets (Solvay Healthcare Ltd) |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Dydrogesterone 10mg tablets 14 tablet |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Duphaston HRT 10mg tablets (Solvay Healthcare Ltd) |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Andropatch 5mg/24hours patches (GlaxoSmithKline) |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Testosterone 5mg/24hours transdermal patches (Special Order) |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Testosterone 5mg/24hours transdermal patches 1 patch |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Duphaston HRT 10mg tablets (Solvay Healthcare Ltd) 42 tablet 3 x 14 tablets |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Testosterone 5mg/24hours transdermal patches (Special Order) 1 patch |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Duphaston 10mg tablets (Solvay Healthcare Ltd) 60 tablet 4 x 15 tablets |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Andropatch 5mg/24hours patches (GlaxoSmithKline) 30 patch |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Dydrogesterone 10mg tablets (Special Order) 1 tablet |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Duphaston 10mg tablets (Solvay Healthcare Ltd) 14 tablet |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Androderm 5mg/24hours transdermal patches (Imported (United States)) 30 patch |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Ergocalciferol 300,000units/1ml solution for injection ampoules |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Ergocalciferol 600,000units/2ml solution for injection ampoules |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Ergocalciferol 600,000units/2ml solution for injection ampoules (A A H Pharmaceuticals Ltd) |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Ergocalciferol 600,000units/2ml solution for injection ampoules (Celltech Pharmaceuticals Ltd) |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Ergocalciferol 300,000units/1ml solution for injection ampoules 1 ampoule |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Ergocalciferol 600,000units/2ml solution for injection ampoules 1 ampoule |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Ergocalciferol 300,000units/1ml solution for injection ampoules 10 ampoule |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Ergocalciferol 300,000units/1ml solution for injection ampoules (A A H Pharmaceuticals Ltd) |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Ergocalciferol 600,000units/2ml solution for injection ampoules (Unichem Plc) |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Ergocalciferol 300,000units/1ml solution for injection ampoules (Special Order) |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Ergocalciferol 300,000units/1ml solution for injection ampoules (Celltech Pharmaceuticals Ltd) |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Ergocalciferol 600,000units/2ml solution for injection ampoules 10 ampoule |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Ergocalciferol 600,000units/2ml solution for injection ampoules (Special Order) |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Ergocalciferol 300,000units/1ml solution for injection ampoules (Unichem Plc) |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Ergocalciferol 300,000units/1ml solution for injection ampoules (Celltech Pharmaceuticals Ltd) 10 ampoule 10 x 1ml ampoules |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Ergocalciferol 300,000units/1ml solution for injection ampoules (Unichem Plc) 10 ampoule 10 x 1ml ampoules |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Ergocalciferol 600,000units/2ml solution for injection ampoules (Special Order) 1 ampoule |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Ergocalciferol 600,000units/2ml solution for injection ampoules (A A H Pharmaceuticals Ltd) 10 ampoule 10 x 2ml ampoules |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Ergocalciferol 600,000units/2ml solution for injection ampoules (Celltech Pharmaceuticals Ltd) 10 ampoule 10 x 2ml ampoules |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Ergocalciferol 300,000units/1ml solution for injection ampoules (Special Order) 1 ampoule |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Ergocalciferol 300,000units/1ml solution for injection ampoules (A A H Pharmaceuticals Ltd) 10 ampoule 10 x 1ml ampoules |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Ergocalciferol 600,000units/2ml solution for injection ampoules (Unichem Plc) 10 ampoule 10 x 2ml ampoules |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Product containing precisely tetracycline 250 milligram/1 each conventional release oral capsule |
VMP non-availability indicator |
False |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Tetracycline 250mg capsules 28 capsule |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Achromycin 250mg capsules (Wyeth Laboratories) |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Tetracycline 250mg capsules 1 capsule |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Tetracycline 250mg capsules (Special Order) |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Achromycin 250mg capsules (Wyeth Laboratories) 28 capsule |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Tetracycline 250mg capsules (Special Order) 1 capsule |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Losartan 25mg tablets (Sandoz Ltd) |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Losartan 25mg tablets (Sandoz Ltd) 28 tablet |
VMP non-availability indicator |
True |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Product containing precisely oxprenolol hydrochloride 20 milligram/1 each conventional release oral tablet |
VMP non-availability indicator |
False |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Product containing precisely oxprenolol hydrochloride 40 milligram/1 each conventional release oral tablet |
VMP non-availability indicator |
False |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Oxprenolol 20mg tablets 56 tablet |
VMP non-availability indicator |
False |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Oxprenolol 40mg tablets 56 tablet |
VMP non-availability indicator |
False |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Trasicor 20mg tablets (Amdipharm) |
VMP non-availability indicator |
False |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Trasicor 40mg tablets (Amdipharm) |
VMP non-availability indicator |
False |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Oxprenolol 40mg tablets (Alliance Healthcare (Distribution) Ltd) |
VMP non-availability indicator |
False |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Oxprenolol 20mg tablets (Alliance Healthcare (Distribution) Ltd) |
VMP non-availability indicator |
False |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Oxprenolol 20mg tablets (Alliance Healthcare (Distribution) Ltd) 56 tablet 4 x 14 tablets |
VMP non-availability indicator |
False |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Oxprenolol 40mg tablets (Alliance Healthcare (Distribution) Ltd) 56 tablet 4 x 14 tablets |
VMP non-availability indicator |
False |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Trasicor 40mg tablets (Amdipharm) 56 tablet 4 x 14 tablets |
VMP non-availability indicator |
False |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Trasicor 20mg tablets (Amdipharm) 56 tablet 4 x 14 tablets |
VMP non-availability indicator |
False |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Oxprenolol 20mg tablets (A A H Pharmaceuticals Ltd) |
VMP non-availability indicator |
False |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Oxprenolol 40mg tablets (A A H Pharmaceuticals Ltd) |
VMP non-availability indicator |
False |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|
Oxprenolol 20mg tablets (A A H Pharmaceuticals Ltd) 56 tablet 4 x 14 tablets |
VMP non-availability indicator |
False |
Re-introduced |
Inferred relationship |
Existential restriction modifier |
|